JP2024526849A5 - - Google Patents
Info
- Publication number
- JP2024526849A5 JP2024526849A5 JP2024503400A JP2024503400A JP2024526849A5 JP 2024526849 A5 JP2024526849 A5 JP 2024526849A5 JP 2024503400 A JP2024503400 A JP 2024503400A JP 2024503400 A JP2024503400 A JP 2024503400A JP 2024526849 A5 JP2024526849 A5 JP 2024526849A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- pharmaceutically acceptable
- compound according
- acceptable salt
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163223788P | 2021-07-20 | 2021-07-20 | |
| US63/223,788 | 2021-07-20 | ||
| PCT/US2022/037756 WO2023003973A1 (en) | 2021-07-20 | 2022-07-20 | Inhibitors targeting ubiquitin specific protease 7 (usp7) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024526849A JP2024526849A (ja) | 2024-07-19 |
| JP2024526849A5 true JP2024526849A5 (https=) | 2025-06-27 |
Family
ID=82899138
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024503400A Pending JP2024526849A (ja) | 2021-07-20 | 2022-07-20 | ユビキチン特異的プロテアーゼ７（ｕｓｐ７）を標的とする阻害剤 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240376076A1 (https=) |
| EP (1) | EP4373816A1 (https=) |
| JP (1) | JP2024526849A (https=) |
| CN (1) | CN118401507A (https=) |
| AU (1) | AU2022315201A1 (https=) |
| CA (1) | CA3225596A1 (https=) |
| WO (1) | WO2023003973A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3870179A4 (en) | 2018-10-22 | 2022-11-23 | Dana Farber Cancer Institute, Inc. | USP7 ESCAPEMENT |
| US20240150362A1 (en) | 2022-08-25 | 2024-05-09 | Molecure S.A. | Substituted Pyrrolotriazines |
| CN121135717A (zh) * | 2024-06-14 | 2025-12-16 | 中国科学院上海药物研究所 | 一种靶向泛素化降解usp7蛋白的化合物、其药物组合物和应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA41291A (fr) * | 2014-12-30 | 2017-11-07 | Forma Therapeutics Inc | Dérivés de la pyrrolotriazinone et de l'imidazotriazinone en tant qu'inhibiteurs de la protéase spécifique de l'ubiquitine n° 7 (usp7) pour le traitement d'un cancer |
| AR103297A1 (es) * | 2014-12-30 | 2017-05-03 | Forma Therapeutics Inc | Pirrolo y pirazolopirimidinas como inhibidores de la proteasa 7 específica de ubiquitina |
| GB201617758D0 (en) * | 2016-10-20 | 2016-12-07 | Almac Discovery Limited | Pharmaceutical compounds |
| EP3870179A4 (en) * | 2018-10-22 | 2022-11-23 | Dana Farber Cancer Institute, Inc. | USP7 ESCAPEMENT |
-
2022
- 2022-07-20 EP EP22754635.5A patent/EP4373816A1/en active Pending
- 2022-07-20 JP JP2024503400A patent/JP2024526849A/ja active Pending
- 2022-07-20 CN CN202280051554.7A patent/CN118401507A/zh active Pending
- 2022-07-20 AU AU2022315201A patent/AU2022315201A1/en active Pending
- 2022-07-20 CA CA3225596A patent/CA3225596A1/en active Pending
- 2022-07-20 US US18/580,725 patent/US20240376076A1/en active Pending
- 2022-07-20 WO PCT/US2022/037756 patent/WO2023003973A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024526849A5 (https=) | ||
| JP7536064B2 (ja) | 抗癌活性及び抗増殖活性を呈する２－アミノピリミジン－６－オン及び類似体 | |
| CA3114240C (en) | Imidazopyridine derivatives as alpha4beta7 integrin inhibitors | |
| AU2018362046B2 (en) | Pyrimidine derivatives as inhibitors of PD1/PD-L1 activation | |
| CN104903334B (zh) | 一种替诺福韦前药及其在医药上的应用 | |
| JP2022527114A5 (https=) | ||
| TW202200563A (zh) | 喹喔啉酮衍生物作為kras g12c突變蛋白的不可逆抑制劑 | |
| JP2021529814A (ja) | 化学化合物 | |
| JP2020525513A (ja) | 癌および他の疾患を治療するためのａｔｆ４阻害剤としてのｎ−（３−（２−（４−クロロフェノキシ）アセトアミドビシクロ［１．１．１］ペンタン−１−イル）−２−シクロブタン−１−カルボキサミド誘導体および関連化合物 | |
| JP2016505586A5 (https=) | ||
| JP2021527098A (ja) | 縮合チオフェン化合物 | |
| PT2344449E (pt) | Compostos de aril-fenil-sulfonamido-cicloalquilo e sua utilização | |
| JP2017535589A (ja) | ２−アミノピリミジン系化合物およびその薬物組成物と使用 | |
| JP2017532360A5 (https=) | ||
| JP2010511013A5 (https=) | ||
| JPH06500117A (ja) | 抗腫瘍活性を増強させる２，４−ジアミノキナゾリン誘導体 | |
| JP2010509285A5 (https=) | ||
| JP2008504304A5 (https=) | ||
| TW201014865A (en) | Macrocyclic indole derivatives useful as hepatitis C virus inhibitors | |
| JP2023512557A5 (https=) | ||
| JP2006509842A5 (https=) | ||
| CA3214808A1 (en) | Thienopyrrole compounds | |
| JP6192613B2 (ja) | ニトリル誘導体ならびにそれらの薬学的使用および組成物 | |
| JP6262363B2 (ja) | ブロモドメイン阻害剤としてのキノリン誘導体 | |
| ES2782357T3 (es) | Inhibidores de IRE 1 alfa |